Table 1. Data Collection Protocol for the Mr. Bean Study.
Assessment | Study visit (months) | ||||||
---|---|---|---|---|---|---|---|
0 | 6 | 12 | 18 | 24 | 30 | 36 | |
Interview | |||||||
Demographics | ● | ||||||
Behavioral survey | ● | ● | ● | ● | ● | ● | ● |
Medication review | ● | ● | ● | ● | ● | ● | ● |
Anthropomorphic | |||||||
Height, weight | ● | ● | ● | ● | |||
Blood pressure | ● | ● | ● | ● | |||
Blood tests | |||||||
Creatinine | ● | ● | ● | ● | |||
Lipid panel | ● | ● | ● | ● | |||
Glycosylated hemoglobin | ● | ● | ● | ● | |||
High-sensitivity CRP | ● | ● | ● | ● | |||
Activated CD8 lymphocytes | ● | ● | ● | ● | |||
Phosphorus | ● | ● | ● | ● | |||
HIV RNA1 | ● | ● | ● | ● | |||
CD4 cell count1 | ● | ● | ● | ● | |||
Parathyroid hormone | ● | ||||||
HCV antibody | ● | ||||||
FGF23 | ● | ||||||
Urine tests | |||||||
Creatinine | ● | ● | ● | ● | ● | ● | ● |
Albumin | ● | ● | ● | ● | ● | ● | ● |
Protein | ● | ● | ● | ● | ● | ● | ● |
Dipstick | ● | ● | ● | ● | |||
Phosphorus | ● | ● | ● | ● | |||
Urine drug screen | ● | ● | ● | ● | ● | ● | ● |
Iohexol GFR | ● | ● | ● | ● | |||
Pulse wave velocity | ● | ● | ● | ● | |||
Carotid ultrasound and IMT | ● | ● |
GFR, glomerular filtration rate; IMT, intima-media thickness
1 Testing done in HIV-positive participants